Bank of Montreal’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Bank of Montreal’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-11,499	Closed	-$1K	–	4340
2016 Q3	$1K	Hold	11,499	–	–	﹤0.01%	3988
2016 Q2	$4K	Sell	11,499 -6,000	-34%	-$2.28K	﹤0.01%	3824
2016 Q1	$6K	Buy	17,499 +499	+3%	+$205	﹤0.01%	3766
2015 Q4	$6K	Hold	17,000	–	–	﹤0.01%	3767
2015 Q3	$9K	Hold	17,000	–	–	﹤0.01%	3516
2015 Q2	$9K	Hold	17,000	–	–	﹤0.01%	3531
2015 Q1	$14K	Hold	17,000	–	–	﹤0.01%	3401
2014 Q4	$14K	Hold	17,000	–	–	﹤0.01%	3475
2014 Q3	$17K	Hold	17,000	–	–	﹤0.01%	3527
2014 Q2	$14K	Buy	+17,000	New	+$20.4K	﹤0.01%	3751

Other funds holding PVCT

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

HFBOT

Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return

Bank of Montreal's PVCT Position: Q4 2016 in Review

Bank of Montreal sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2016, closing a stake of 11,499 shares — an estimated $1K sold.

Bank of Montreal first reported a position in PVCT in Q2 2014 and held it in 10 quarters. The position peaked at $17K in Q3 2014. 8 funds tracked by Wall St. Rank hold PVCT as of Q4 2016.

Bank of Montreal reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2016 after selling out during the quarter.
Bank of Montreal sold 11,499 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2016, an estimated $1K.
Bank of Montreal first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q2 2014 and held it in 10 quarters.
Bank of Montreal's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $17K in Q3 2014.
8 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2016.

Based on Bank of Montreal's 13F filing for Q4 2016, filed 6 Feb 2017.